Firefly neuroscience partners with healingmaps to offer cognitive electrophysiology analytics to over 2,500 ketamine, psilocybin, and tms clinics across north america

Kenmore, n.y. and miami, sept. 05, 2025 (globe newswire) -- firefly neuroscience, inc. (“firefly”) (nasdaq: aiff), an artificial intelligence (“ai”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with healingmaps, the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation (“tms”) clinics, and advanced behavioral strategies (abs).
AIFF Ratings Summary
AIFF Quant Ranking